<DOC>
	<DOCNO>NCT01714193</DOCNO>
	<brief_summary>The purpose study investigate whether drug-drug interaction multiple dose canagliflozin ( JNJ-28431754 ) single dose oral contraceptive contain ethinyl estradiol levonorgestrel . The safety tolerability canagliflozin also assess healthy volunteer .</brief_summary>
	<brief_title>A Study Assess Effects Canagliflozin ( JNJ-28431754 ) Pharmacokinetics Safety Oral Contraceptive Healthy Volunteers</brief_title>
	<detailed_description>This study open-label ( volunteer study staff know identity assign treatment ) , single-center , fixed-sequence study ( volunteer receive medication day ) , determine canagliflozin ( drug currently investigate treatment type 2 diabetes mellitus ) affect pharmacokinetics ( ie , body affect drug ) oral contraceptive contain ethinyl estradiol levonorgestrel . The study consist 3 phase ; screen phase , open-label treatment phase , end-of-study ( follow-up ) phase . Each volunteer participate study approximately 33 day .</detailed_description>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Canagliflozin</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Volunteer must body mass index ( weight [ kg ] /height [ m2 ] ) 18 30 kg/m2 ( inclusive ) , body weight less 50 kg Volunteer must nonsmoker ( use tobacco nicotine product 6 month ) History currently active illness consider clinically significant Investigator illness Investigator considers exclude patient study could interfere interpretation study result History , presence , disorder commonly accept contraindication sex hormonal therapy contraindication therapy combine oral contraceptive Volunteer use , currently use , hormonal contraceptive within 30 day admission study center receive Depo Provera ( combine contraceptive injection hormonal contraceptive implant ) 6 month prior screen Volunteer breastfeeding</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Canagliflozin ( JNJ-28431754 )</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Contraceptives , Oral</keyword>
	<keyword>Ethinyl Estradiol</keyword>
	<keyword>Levonorgestrel</keyword>
	<keyword>LEVORA</keyword>
</DOC>